Goldstein L B, Bonito A J, Matchar D B, Duncan P W, Samsa G P
Center for Health Policy Research and Education, Duke University, Durham, NC; USA.
Stroke. 1996 Sep;27(9):1473-8. doi: 10.1161/01.str.27.9.1473.
Aspirin or other platelet antiaggregants and anticoagulants are commonly used in many types of patients at elevated stroke risk. However, relatively little is known concerning how practicing physicians use these medications in their patients with extracranial carotid artery stenosis. The identification of variations in practice may help to both direct specific educational efforts and guide further research.
Between August 1993 and February 1994, we surveyed the stroke prevention practices of a stratified random sample of 2000 US physicians. The survey included clinical scenarios that probed the use of aspirin or other platelet antiaggregants and anticoagulants in symptomatic and asymptomatic patients with carotid artery stenoses of 50% to 70% or more than 70%, with and without known surgical contraindications.
Sixty-seven percent of those eligible completed the survey (n = 1006). More than 85% of physicians responded that they always or often prescribe aspirin or other platelet antiaggregants regardless of degree of carotid artery stenosis, symptom status, or presence of surgical contraindications. However, the reported frequency of use of these medications varied independently according to physician specialty (P = .044). In contrast, in addition to physician specialty, the reported frequency of anticoagulant use varied independently with degree of carotid artery stenosis, symptom status, and presence of surgical contraindications (P < .0001 for each variable). Fifteen percent of physicians responded that they always or often use anticoagulants for asymptomatic patients with 50% to 70% carotid artery stenosis versus 43% who reported doing so for symptomatic patients with a similar degree of stenosis (P < .001); 28% often or always prescribe anticoagulants for asymptomatic patients with more than 70% carotid artery stenosis versus 49% who do so if symptoms are present (P < .001). The odds of noninternist primary care physicians responding that they always or often use anticoagulants were more than five times higher (odds ratio, 5.32; 95% confidence interval [CI], 3.79 to 7.45) than surgical specialists. Compared with surgical specialists, the odds ratios for the use of anticoagulants were 3.65 for internists (95% CI, 2.63 to 5.06) and 1.88 (95% CI, 1.40 to 2.53) for neurologists.
These data show the following: (1) Aspirin or other platelet antiaggregants are used by most physicians regardless of degree of carotid artery stenosis, symptom status, or presence of surgical contraindications; (2) anticoagulants are prescribed selectively, with each of these variables influencing their use; and (3) the use of both classes of agents varies with physician specialty training.
阿司匹林或其他血小板抗聚集剂及抗凝剂常用于许多中风风险升高的患者类型。然而,关于执业医师如何在患有颅外颈动脉狭窄的患者中使用这些药物,我们所知相对较少。识别实践中的差异可能有助于指导具体的教育工作并引导进一步的研究。
在1993年8月至1994年2月期间,我们对2000名美国医师的分层随机样本的中风预防实践进行了调查。该调查包括一些临床场景,探究了阿司匹林或其他血小板抗聚集剂及抗凝剂在有症状和无症状的、颈动脉狭窄50%至70%或超过70%且有或无已知手术禁忌症的患者中的使用情况。
67%的符合条件者完成了调查(n = 1006)。超过85%的医师表示,无论颈动脉狭窄程度、症状状态或是否存在手术禁忌症,他们总是或经常开具阿司匹林或其他血小板抗聚集剂。然而,这些药物的报告使用频率因医师专业而异(P = .044)。相比之下,除医师专业外,抗凝剂的报告使用频率还独立于颈动脉狭窄程度、症状状态和手术禁忌症的存在情况而变化(每个变量P < .0001)。15%的医师表示,他们总是或经常对颈动脉狭窄50%至70%的无症状患者使用抗凝剂,而对于狭窄程度相似的有症状患者,这一比例为43%(P < .001);28%的医师经常或总是对颈动脉狭窄超过70%的无症状患者开具抗凝剂,而有症状时这一比例为49%(P < .001)。非内科初级保健医师表示总是或经常使用抗凝剂的几率比外科专家高出五倍多(优势比,5.32;95%置信区间[CI],3.79至7.45)。与外科专家相比,内科医师使用抗凝剂的优势比为3.65(95%CI,2.63至5.06),神经科医师为1.88(95%CI,1.40至2.53)。
这些数据表明:(1)大多数医师使用阿司匹林或其他血小板抗聚集剂,而不考虑颈动脉狭窄程度、症状状态或手术禁忌症的存在;(2)抗凝剂是选择性开具的,这些变量中的每一个都会影响其使用;(3)这两类药物的使用因医师专业培训而异。